Dr. Avinash V. Mantravadi, MD

Dr. Mantravadi practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Mantravadi's NPI, 1174789564, was assigned on August 5, 2008. Dr. Mantravadi graduated from Indiana University School of Medicine in 2007. Dr. Mantravadi holds Indiana license 01072985A.

Dr. Mantravadi's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Mantravadi's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Mantravadi is also affiliated with IU Health West Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Mantravadi to 1 more hospital, 2 group practices and clinics, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mantravadi practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Mantravadi's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Mantravadi's licenses on file in 3 states: Indiana, Florida and Illinois.

CMS data shows 131 Medicare services from Dr. Mantravadi across 5 procedure codes in 2024, for 114 Medicare patients. Medicare paid $9,372 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 114 Medicare patients who saw Dr. Mantravadi in 2024. The largest group is 65 to 74, with 59 patients. 73% of them have high cholesterol, and 69% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mantravadi's median patient age at 63, with 50% women.

In 2024, Dr. Mantravadi wrote 105 Medicare Part D claims for 39 patients. 98% of them were for generic drugs. CMS names the drug for 39 of them, across 3 drugs with 11 or more claims each, at $882 in total drug cost. In 2023, CMS named 35 claims across 2 drugs.

Dr. Mantravadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of melanoma (skin cancer) excision by Dr. Mantravadi, more than 66% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Mantravadi, published from 2011 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Postoperative Complications and Plastic Surgery Procedures. Dr. Mantravadi has published most often in Otolaryngol Head Neck Surg. Dr. Mantravadi's most frequent co-authors are Michael W. Sim, MD, Jessica A. Yesensky, MD and Alexander Joseph Jones, MD.

CMS Open Payments shows 25 general payments to Dr. Mantravadi from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Cook Medical LLC paid the most, $4,445.

Dr. Mantravadi graduated from Indiana University School of Medicine in 2007.